News
-
-
COMMUNIQUÉ DE PRESSE
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies -
-
COMMUNIQUÉ DE PRESSE
Katjes International acquires UK healthy snacking brand Graze from Unilever
Katjes International acquires UK healthy snacking brand Graze from Unilever. Agreement signed for full brand and product portfolio, including production facility in London. Transaction expected to close in first half of 2026 -
COMMUNIQUÉ DE PRESSE
Publication mensuelle du nombre d'actions composant le capital et du nombre total de droits de vote
Rapport mensuel relatif au nombre d'actions et de droits de vote de la société pour les mois de septembre, octobre et novembre 2025 en conformité avec l'article 223-16 du Règlement général de l'AMF -
-
COMMUNIQUÉ DE PRESSE
DenizBank AG Supports Critical Healthcare Infrastructure with €96 Million OeKB Shopping Line Facility for Rönesans Holding
DenizBank AG supports Rönesans Holding with €96 million OeKB Shopping Line facility for critical healthcare and infrastructure projects in Turkey, promoting international cooperation and sustainable development -
-
COMMUNIQUÉ DE PRESSE
Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms BUY rating for LAIQON AG with target price of €10.50 after announcing strategic partnership with Amundi for AI-driven ETF. Partnership seen as major milestone for LAIQON's technology expansion and market access -
